Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Cerilliant
UBS
Express Scripts
Argus Health
QuintilesIMS
Accenture
Covington

Generated: April 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011837

« Back to Dashboard

NDA 011837 describes ALPHA CHYMAR, which is a drug marketed by Sola Barnes Hind and is included in one NDA. Additional details are available on the ALPHA CHYMAR profile page.

The generic ingredient in ALPHA CHYMAR is chymotrypsin. There are nine drug master file entries for this compound. Additional details are available on the chymotrypsin profile page.
Summary for 011837
Tradename:ALPHA CHYMAR
Applicant:Sola Barnes Hind
Ingredient:chymotrypsin
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FOR SOLUTION;OPHTHALMICStrength750 UNITS/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Healthtrust
Moodys
Chubb
Dow
Daiichi Sankyo
Deloitte
Accenture
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.